Evidence map›Paper›PMID 38030848›Full record

ArticleMikrochimica acta2023

Self-assembled miR-134-5p inhibitor nanoparticles ameliorate experimental bronchopulmonary dysplasia (BPD) via suppressing ferroptosis.

Jiang Lan, Xu Chen, Fengdan Xu, Fangfei Tao, Liyuan Liu, Rui Cheng, Ning Li, Ya Pan

Open access · hybridAbstract read
In one paragraph

Article in Mikrochimica acta, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Ferroptosis inhibitors: past, present and future.Frontiers in pharmacology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Jiang LanShenzhen Longhua Maternity and Child Health Care Hospital, Shenzhen, 518000, China.
Xu Chen *Children's Hospital Affiliated to Nanjing Medical University (Nanjing Children's Hospital), Nanjing, 210008, China.
Fengdan Xu *Dongguan Children's Hospital Affiliated to Guangdong Medical University, Dongguan, 523325, China.
Fangfei TaoChildren's Hospital Affiliated to Nanjing Medical University (Nanjing Children's Hospital), Nanjing, 210008, China.
Liyuan LiuShenzhen Longhua Maternity and Child Health Care Hospital, Shenzhen, 518000, China.
Rui ChengChildren's Hospital Affiliated to Nanjing Medical University (Nanjing Children's Hospital), Nanjing, 210008, China. chengrui350@163.com.
Ning LiDongguan Children's Hospital Affiliated to Guangdong Medical University, Dongguan, 523325, China. mean163@163.com.
Ya PanShenzhen Longhua Maternity and Child Health Care Hospital, Shenzhen, 518000, China. panya1979@163.com.
Nanjing Medical University · CNGuangdong Medical College · CNShenzhen Maternity and Child Healthcare Hospital · CNTongren Hospital · CN

Funding

This study was supported by grants from the Technology Development Project of Dongguan, China (No.20221800905362)
6 · The paper itself

Abstract

Bronchopulmonary dysplasia (BPD) is a chronic lung disease in premature infants with increased levels of reactive oxygen species (ROS) and ferroptosis. Herein, we designed a peptide-based nanoparticle to deliver therapeutic molecules to pulmonary, thereby ameliorating BPD. The BPD-induced damages of lung tissues were detected by H&E and immunohistochemistry staining. Inflammatory cytokines, Fe

Indexed as

Bronchopulmonary DysplasiaFerroptosisMicroRNAsNanoparticlesAnimalsCytokinesHumansInfantInfant, NewbornMiceReactive Oxygen SpeciesCytokinesMicroRNAsMIRN134 microRNA, humanReactive Oxygen SpeciesDynamic light scatteringExperimental bronchopulmonary dysplasiaFerroptosisLuminescence imagingmiR-134-5pNanometer materialsNanoparticlesTEM

Identifiers

PMID38030848
PMCPMC10687138
OpenAlexW4389180107

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.